US Patent Issued to Bristol-Myers Squibb on July 14 for "Oxopyrrolidine FPR2 agonists" (Indian, American Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,823, issued on July 14, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Oxopyrrolidine FPR2 agonists" was invented by Pravin Sudhakar Shirude (Bangalore, India), Chandrasekhar Reddy Rachamreddy (Kadapa District, India), Amit Kumar Chattopadhyay (Bangalore, India), Balaji Seshadri (Bangalore, India), Vishweshwaraiah Baligar (Bangalore, India), Sudhakara Reddy Madduri (Bangalore, India), Ellen K. Kick (Pennington, N.J.) and Nicholas R. Wurtz (Pennington, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds of Formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) ...